BMRN logo

BioMarin Pharmaceutical Inc. (BMRN) Depreciation and amortization

annual D&A:

$96.43M-$7.96M(-7.63%)
December 31, 2024

Summary

  • As of today (September 9, 2025), BMRN annual depreciation & amortization is $96.43 million, with the most recent change of -$7.96 million (-7.63%) on December 31, 2024.
  • During the last 3 years, BMRN annual D&A has fallen by -$11.61 million (-10.75%).
  • BMRN annual D&A is now -10.75% below its all-time high of $108.04 million, reached on December 31, 2021.

Performance

BMRN Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

quarterly D&A:

$18.56M-$3.51M(-15.89%)
June 30, 2025

Summary

  • As of today (September 9, 2025), BMRN quarterly depreciation & amortization is $18.56 million, with the most recent change of -$3.51 million (-15.89%) on June 30, 2025.
  • Over the past year, BMRN quarterly D&A has dropped by -$7.90 million (-29.85%).
  • BMRN quarterly D&A is now -39.61% below its all-time high of $30.74 million, reached on September 30, 2019.

Performance

BMRN quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

TTM D&A:

$83.25M-$7.90M(-8.67%)
June 30, 2025

Summary

  • As of today (September 9, 2025), BMRN TTM depreciation & amortization is $83.25 million, with the most recent change of -$7.90 million (-8.67%) on June 30, 2025.
  • Over the past year, BMRN TTM D&A has dropped by -$23.11 million (-21.73%).
  • BMRN TTM D&A is now -23.92% below its all-time high of $109.41 million, reached on September 30, 2021.

Performance

BMRN TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

BMRN Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-7.6%-29.9%-21.7%
3 y3 years-10.8%-26.5%-21.1%
5 y5 years-8.4%-26.4%-22.7%

BMRN Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-10.8%at low-32.1%at low-21.7%at low
5 y5-year-10.8%at low-33.7%at low-23.9%at low
alltimeall time-10.8%>+9999.0%-39.6%+4318.7%-23.9%>+9999.0%

BMRN Depreciation and amortization History

DateAnnualQuarterlyTTM
Jun 2025
-
$18.56M(-15.9%)
$83.25M(-8.7%)
Mar 2025
-
$22.07M(-6.5%)
$91.14M(-5.5%)
Dec 2024
$96.43M(-7.6%)
$23.61M(+24.2%)
$96.43M(-3.3%)
Sep 2024
-
$19.01M(-28.2%)
$99.68M(-6.3%)
Jun 2024
-
$26.46M(-3.2%)
$106.36M(+1.0%)
Mar 2024
-
$27.35M(+1.8%)
$105.31M(+0.9%)
Dec 2023
$104.39M(+2.4%)
$26.86M(+4.6%)
$104.39M(+2.3%)
Sep 2023
-
$25.68M(+1.0%)
$102.08M(+0.9%)
Jun 2023
-
$25.42M(-3.8%)
$101.19M(+0.1%)
Mar 2023
-
$26.42M(+7.6%)
$101.05M(-0.9%)
Dec 2022
$101.97M(-5.6%)
$24.55M(-1.0%)
$101.97M(-1.4%)
Sep 2022
-
$24.80M(-1.9%)
$103.40M(-1.9%)
Jun 2022
-
$25.27M(-7.6%)
$105.44M(-1.8%)
Mar 2022
-
$27.34M(+5.2%)
$107.40M(-0.6%)
Dec 2021
$108.04M(+2.7%)
$25.99M(-3.2%)
$108.04M(-1.3%)
Sep 2021
-
$26.84M(-1.4%)
$109.41M(+0.2%)
Jun 2021
-
$27.23M(-2.7%)
$109.21M(+1.9%)
Mar 2021
-
$27.98M(+2.3%)
$107.19M(+1.9%)
Dec 2020
$105.17M(-0.1%)
$27.36M(+2.7%)
$105.17M(+1.5%)
Sep 2020
-
$26.63M(+5.6%)
$103.60M(-3.8%)
Jun 2020
-
$25.22M(-2.9%)
$107.71M(-1.0%)
Mar 2020
-
$25.96M(+0.7%)
$108.84M(+3.4%)
Dec 2019
$105.30M(+10.1%)
$25.79M(-16.1%)
$105.30M(+1.0%)
Sep 2019
-
$30.74M(+16.7%)
$104.23M(+4.4%)
Jun 2019
-
$26.34M(+17.5%)
$99.83M(+5.7%)
Mar 2019
-
$22.43M(-9.3%)
$94.47M(-1.3%)
Dec 2018
$95.67M(+8.9%)
$24.72M(-6.2%)
$95.67M(-4.0%)
Sep 2018
-
$26.34M(+25.6%)
$99.62M(+6.0%)
Jun 2018
-
$20.98M(-11.2%)
$93.97M(+2.1%)
Mar 2018
-
$23.63M(-17.6%)
$92.08M(+4.8%)
Dec 2017
$87.86M(-9.3%)
$28.66M(+38.5%)
$87.86M(+10.8%)
Sep 2017
-
$20.70M(+8.5%)
$79.30M(-9.9%)
Jun 2017
-
$19.09M(-1.7%)
$88.03M(-9.8%)
Mar 2017
-
$19.41M(-3.5%)
$97.60M(+0.7%)
Dec 2016
$96.91M(+105.4%)
$20.11M(-31.7%)
$96.91M(+23.2%)
Sep 2016
-
$29.42M(+2.7%)
$78.69M(+21.1%)
Jun 2016
-
$28.66M(+53.0%)
$64.99M(+26.2%)
Mar 2016
-
$18.73M(+895.5%)
$51.52M(+9.2%)
Dec 2015
$47.19M(-16.8%)
$1.88M(-88.0%)
$47.19M(-24.0%)
Sep 2015
-
$15.73M(+3.6%)
$62.13M(+2.5%)
Jun 2015
-
$15.18M(+5.5%)
$60.62M(+2.5%)
Mar 2015
-
$14.40M(-14.4%)
$59.12M(+4.2%)
Dec 2014
$56.74M(+20.1%)
$16.82M(+18.3%)
$56.74M(+15.1%)
Sep 2014
-
$14.22M(+4.0%)
$49.30M(+1.7%)
Jun 2014
-
$13.68M(+13.8%)
$48.46M(+1.5%)
Mar 2014
-
$12.02M(+28.1%)
$47.72M(+1.0%)
Dec 2013
$47.26M(+4.3%)
$9.38M(-29.8%)
$47.26M(-5.0%)
Sep 2013
-
$13.38M(+3.4%)
$49.74M(+3.6%)
Jun 2013
-
$12.94M(+11.9%)
$48.03M(+3.8%)
Mar 2013
-
$11.56M(-2.5%)
$46.26M(+2.1%)
Dec 2012
$45.30M(+25.5%)
$11.86M(+1.6%)
$45.30M(+5.2%)
Sep 2012
-
$11.67M(+4.4%)
$43.07M(+5.7%)
Jun 2012
-
$11.17M(+5.4%)
$40.75M(+6.9%)
Mar 2012
-
$10.60M(+10.1%)
$38.11M(+5.6%)
DateAnnualQuarterlyTTM
Dec 2011
$36.09M(+30.1%)
$9.63M(+3.0%)
$36.09M(+4.9%)
Sep 2011
-
$9.35M(+9.6%)
$34.40M(+4.7%)
Jun 2011
-
$8.53M(-0.6%)
$32.87M(+6.3%)
Mar 2011
-
$8.59M(+8.2%)
$30.91M(+11.4%)
Dec 2010
$27.74M(+32.2%)
$7.93M(+1.4%)
$27.74M(+12.4%)
Sep 2010
-
$7.82M(+18.9%)
$24.67M(+13.7%)
Jun 2010
-
$6.58M(+21.6%)
$21.69M(+1.9%)
Mar 2010
-
$5.41M(+11.3%)
$21.28M(+1.5%)
Dec 2009
$20.98M(+19.0%)
$4.86M(+0.4%)
$20.98M(+0.5%)
Sep 2009
-
$4.84M(-21.5%)
$20.87M(+1.4%)
Jun 2009
-
$6.17M(+20.9%)
$20.58M(+9.1%)
Mar 2009
-
$5.10M(+7.3%)
$18.86M(+7.0%)
Dec 2008
$17.63M(+30.2%)
$4.76M(+4.5%)
$17.63M(+6.3%)
Sep 2008
-
$4.55M(+2.3%)
$16.58M(+6.9%)
Jun 2008
-
$4.45M(+15.0%)
$15.51M(+7.9%)
Mar 2008
-
$3.87M(+4.5%)
$14.38M(+6.2%)
Dec 2007
$13.54M(+13.3%)
$3.71M(+6.2%)
$13.54M(+9.2%)
Sep 2007
-
$3.49M(+5.3%)
$12.40M(+3.4%)
Jun 2007
-
$3.31M(+9.1%)
$12.00M(-3.7%)
Mar 2007
-
$3.04M(+18.5%)
$12.46M(+4.2%)
Dec 2006
$11.96M(+18.7%)
$2.56M(-17.0%)
$11.96M(-1.8%)
Sep 2006
-
$3.09M(-18.3%)
$12.17M(+5.7%)
Jun 2006
-
$3.78M(+49.0%)
$11.52M(+13.5%)
Mar 2006
-
$2.54M(-8.6%)
$10.14M(+0.7%)
Dec 2005
$10.07M(-24.1%)
$2.77M(+14.2%)
$10.07M(+27.5%)
Sep 2005
-
$2.43M(+1.0%)
$7.90M(-32.4%)
Jun 2005
-
$2.40M(-2.5%)
$11.68M(-13.5%)
Mar 2005
-
$2.47M(+311.7%)
$13.49M(+1.6%)
Dec 2004
$13.28M(+40.6%)
$599.00K(-90.4%)
$13.28M(-11.9%)
Sep 2004
-
$6.21M(+47.1%)
$15.06M(+27.8%)
Jun 2004
-
$4.22M(+87.5%)
$11.79M(+22.7%)
Mar 2004
-
$2.25M(-5.6%)
$9.61M(+1.8%)
Dec 2003
$9.44M(+11.0%)
$2.38M(-18.7%)
$9.44M(-0.6%)
Sep 2003
-
$2.93M(+43.7%)
$9.50M(+7.9%)
Jun 2003
-
$2.04M(-2.2%)
$8.81M(+0.8%)
Mar 2003
-
$2.08M(-14.7%)
$8.74M(+2.7%)
Dec 2002
$8.50M(+37.8%)
$2.44M(+9.2%)
$8.50M(+1.2%)
Sep 2002
-
$2.24M(+13.7%)
$8.40M(+11.3%)
Jun 2002
-
$1.97M(+6.3%)
$7.55M(+10.0%)
Mar 2002
-
$1.85M(-21.1%)
$6.86M(+11.2%)
Dec 2001
$6.17M(+3.8%)
$2.35M(+69.6%)
$6.17M(+13.9%)
Sep 2001
-
$1.38M(+7.9%)
$5.42M(-3.2%)
Jun 2001
-
$1.28M(+10.3%)
$5.60M(-0.8%)
Mar 2001
-
$1.16M(-27.1%)
$5.64M(-5.1%)
Dec 2000
$5.95M(+14.0%)
$1.59M(+2.2%)
$5.95M(-6.7%)
Sep 2000
-
$1.56M(+17.6%)
$6.38M(-0.8%)
Jun 2000
-
$1.33M(-9.5%)
$6.43M(+2.6%)
Mar 2000
-
$1.47M(-27.5%)
$6.26M(+20.0%)
Dec 1999
$5.22M(+801.2%)
$2.02M(+25.5%)
$5.22M(+63.3%)
Sep 1999
-
$1.61M(+38.7%)
$3.19M(+101.9%)
Jun 1999
-
$1.16M(+176.6%)
$1.58M(+276.6%)
Mar 1999
-
$420.10K
$420.10K
Dec 1998
$578.90K(>+9900.0%)
-
-
Dec 1997
$4800.00
-
-

FAQ

  • What is BioMarin Pharmaceutical Inc. annual depreciation & amortization?
  • What is the all time high annual D&A for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. annual D&A year-on-year change?
  • What is BioMarin Pharmaceutical Inc. quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. quarterly D&A year-on-year change?
  • What is BioMarin Pharmaceutical Inc. TTM depreciation & amortization?
  • What is the all time high TTM D&A for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. TTM D&A year-on-year change?

What is BioMarin Pharmaceutical Inc. annual depreciation & amortization?

The current annual D&A of BMRN is $96.43M

What is the all time high annual D&A for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high annual depreciation & amortization is $108.04M

What is BioMarin Pharmaceutical Inc. annual D&A year-on-year change?

Over the past year, BMRN annual depreciation & amortization has changed by -$7.96M (-7.63%)

What is BioMarin Pharmaceutical Inc. quarterly depreciation & amortization?

The current quarterly D&A of BMRN is $18.56M

What is the all time high quarterly D&A for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high quarterly depreciation & amortization is $30.74M

What is BioMarin Pharmaceutical Inc. quarterly D&A year-on-year change?

Over the past year, BMRN quarterly depreciation & amortization has changed by -$7.90M (-29.85%)

What is BioMarin Pharmaceutical Inc. TTM depreciation & amortization?

The current TTM D&A of BMRN is $83.25M

What is the all time high TTM D&A for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high TTM depreciation & amortization is $109.41M

What is BioMarin Pharmaceutical Inc. TTM D&A year-on-year change?

Over the past year, BMRN TTM depreciation & amortization has changed by -$23.11M (-21.73%)
On this page